Amgen (AMGN) Q2 2024 Earnings
AMGN·Reported August 6, 2024·After market close
Amgen reported Q2 2024 revenue of $8.4B, beat analyst consensus of $8.4B by $36.1M. Diluted EPS came in at $4.97, missed the $4.98 consensus by $0.01. Amgen reports across 1 business segment, led by Human Therapeutics.
Revenue
$8.4Bbeat by $36.1M
Consensus: $8.4BDiluted EPS
$4.97missed by $0.01
Consensus: $4.98
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Amgen's Q2 2024 earnings report.
Amgen (AMGN) reported Q2 2024 earnings on August 6, 2024 after market close.
Amgen reported revenue of $8.4B and diluted EPS of $4.97 for Q2 2024.
Revenue beat the consensus estimate of $8.4B by $36.1M. EPS missed the consensus estimate of $4.98 by $0.01.
You can read the 10-Q periodic report (0000318154-24-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.